Cargando…
Congenital Hemolytic Anemias: Is There a Role for the Immune System?
Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324678/ https://www.ncbi.nlm.nih.gov/pubmed/32655575 http://dx.doi.org/10.3389/fimmu.2020.01309 |
_version_ | 1783551989019312128 |
---|---|
author | Zaninoni, Anna Fermo, Elisa Vercellati, Cristina Marcello, Anna Paola Barcellini, Wilma Bianchi, Paola |
author_facet | Zaninoni, Anna Fermo, Elisa Vercellati, Cristina Marcello, Anna Paola Barcellini, Wilma Bianchi, Paola |
author_sort | Zaninoni, Anna |
collection | PubMed |
description | Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduced erythrocyte life span, splenomegaly, jaundice, biliary lithiasis, and iron overload. Although few data are reported on the role of the immune system in CHAs, several immune-mediated mechanisms may be involved in the pathogenesis of these rare diseases. We reported in ~60% of patients with hereditary spherocytosis (HS), the presence of naturally-occurring autoantibodies (NAbs) directed against different membrane proteins (α- and β-spectrin, band 3, and dematin). Positive HS subjects showed a more hemolytic pattern and NAbs were more evident in aged erythrocytes. The latter is in line with the function of NAbs in the opsonization of damaged/senescent erythrocytes and their consequent removal in the spleen. Splenectomy, usually performed to reduce erythrocyte catheresis and improve Hb levels, has different efficacy in various CHAs. Median Hb increase is 3 g/dL in HS, 1.6–1.8 g/dL in pyruvate kinase deficiency (PKD), and 1 g/dL in congenital dyserythropoietic anemias (CDA) type II. Consistently with clinical severity, splenectomy is performed in 20% of HS, 45% of CDAII, and in 60% of PKD patients. Importantly, sepsis and thrombotic events have been registered, particularly in PKD with a frequency of ~7% for both. Furthermore, we analyzed the role of pro-inflammatory cytokines and found that interleukin 10 and interferon γ, and to a lesser extent interleukin 6, were increased in all CHAs compared with controls. Moreover, CDAII and enzymatic defects showed increased tumor necrosis factor-α and reduced interleukin 17. Finally, we reported that iron overload occurred in 31% of patients with membrane defects, in ~60% of CDAII cases, and in up to 82% of PKD patients (defined by MRI liver iron concentration >4 mg Fe/gdw). Hepcidin was slightly increased in CHAs compared with controls and positively correlated with ferritin and with the inflammatory cytokines interleukin 6 and interferon γ. Overall the results suggest the existence of a vicious circle between chronic hemolysis, inflammatory response, bone marrow dyserythropoiesis, and iron overload. |
format | Online Article Text |
id | pubmed-7324678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73246782020-07-10 Congenital Hemolytic Anemias: Is There a Role for the Immune System? Zaninoni, Anna Fermo, Elisa Vercellati, Cristina Marcello, Anna Paola Barcellini, Wilma Bianchi, Paola Front Immunol Immunology Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduced erythrocyte life span, splenomegaly, jaundice, biliary lithiasis, and iron overload. Although few data are reported on the role of the immune system in CHAs, several immune-mediated mechanisms may be involved in the pathogenesis of these rare diseases. We reported in ~60% of patients with hereditary spherocytosis (HS), the presence of naturally-occurring autoantibodies (NAbs) directed against different membrane proteins (α- and β-spectrin, band 3, and dematin). Positive HS subjects showed a more hemolytic pattern and NAbs were more evident in aged erythrocytes. The latter is in line with the function of NAbs in the opsonization of damaged/senescent erythrocytes and their consequent removal in the spleen. Splenectomy, usually performed to reduce erythrocyte catheresis and improve Hb levels, has different efficacy in various CHAs. Median Hb increase is 3 g/dL in HS, 1.6–1.8 g/dL in pyruvate kinase deficiency (PKD), and 1 g/dL in congenital dyserythropoietic anemias (CDA) type II. Consistently with clinical severity, splenectomy is performed in 20% of HS, 45% of CDAII, and in 60% of PKD patients. Importantly, sepsis and thrombotic events have been registered, particularly in PKD with a frequency of ~7% for both. Furthermore, we analyzed the role of pro-inflammatory cytokines and found that interleukin 10 and interferon γ, and to a lesser extent interleukin 6, were increased in all CHAs compared with controls. Moreover, CDAII and enzymatic defects showed increased tumor necrosis factor-α and reduced interleukin 17. Finally, we reported that iron overload occurred in 31% of patients with membrane defects, in ~60% of CDAII cases, and in up to 82% of PKD patients (defined by MRI liver iron concentration >4 mg Fe/gdw). Hepcidin was slightly increased in CHAs compared with controls and positively correlated with ferritin and with the inflammatory cytokines interleukin 6 and interferon γ. Overall the results suggest the existence of a vicious circle between chronic hemolysis, inflammatory response, bone marrow dyserythropoiesis, and iron overload. Frontiers Media S.A. 2020-06-23 /pmc/articles/PMC7324678/ /pubmed/32655575 http://dx.doi.org/10.3389/fimmu.2020.01309 Text en Copyright © 2020 Zaninoni, Fermo, Vercellati, Marcello, Barcellini and Bianchi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zaninoni, Anna Fermo, Elisa Vercellati, Cristina Marcello, Anna Paola Barcellini, Wilma Bianchi, Paola Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title | Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title_full | Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title_fullStr | Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title_full_unstemmed | Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title_short | Congenital Hemolytic Anemias: Is There a Role for the Immune System? |
title_sort | congenital hemolytic anemias: is there a role for the immune system? |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324678/ https://www.ncbi.nlm.nih.gov/pubmed/32655575 http://dx.doi.org/10.3389/fimmu.2020.01309 |
work_keys_str_mv | AT zaninonianna congenitalhemolyticanemiasistherearolefortheimmunesystem AT fermoelisa congenitalhemolyticanemiasistherearolefortheimmunesystem AT vercellaticristina congenitalhemolyticanemiasistherearolefortheimmunesystem AT marcelloannapaola congenitalhemolyticanemiasistherearolefortheimmunesystem AT barcelliniwilma congenitalhemolyticanemiasistherearolefortheimmunesystem AT bianchipaola congenitalhemolyticanemiasistherearolefortheimmunesystem |